inhibitors also known dihydrotestosterone dht blockers class medications antiandrogenic effects used primarily treatment enlarged prostate scalp hair loss also sometimes used treat excess hair growth women component hormone therapy transgender agents inhibit enzyme involved metabolic transformations variety endogenous steroids known preventing conversion testosterone major androgen sex hormone potent androgen dihydrotestosterone dht certain androgenassociated disorders clinically used treatment conditions exacerbated used treatment hirsutism usefulness potential treatment acne sometimes used antiandrogens feminizing hormone therapy transgender women help reduce body hair growth scalp hair also explored treatment prevention prostate cancer finasteride reduces cancer risk third also increases fraction aggressive forms prostate cancer overall seem survival benefit prostate cancer patients finasteride brand names proscar propecia inhibits function two isoenzymes types decreases circulating dht levels dutasteride brand name avodart inhibits three isoenzymes decrease dht levels also reduce dht levels prostate men prostate epristeride brand names aipuliete chuanliu marketed china treatment benign prostatic however decrease circulating dht levels alfatradiol brand names ellcranell alpha pantostin topical used treat pattern hair loss extract serenoa repens also known saw palmetto extract sold overthecounter dietary supplement also used brand name permixon europe pharmaceutical drug treatment benign prostatic hyperplasia generally well tolerated men women produce side however found risks studies men including slightly increased risks decreased libido erectile dysfunction ejaculatory dysfunction infertility breast tenderness gynecomastia depression anxiety selfharm addition although decrease overall risk developing prostate cancer found increase risk developing certain rare highgrade forms prostate result fda notified healthcare professionals warnings precautions section labels class drugs revised include new safety information increased risk diagnosed rare serious forms prostate finasteride also associated intraoperative floppy iris syndrome cataract depressive symptoms suicidality sexual dysfunction including erectile dysfunction loss libido reduced ejaculate may occur men treated finasteride linked lower quality life cause stress also association lowered sexual reported subset men adverse sexual side effects may persist even discontinuation finasteride small risk breast changes men including breast tenderness gynecomastia breast risk gynecomastia association male breast populationbased matchedcohort study men aged years older bph found finasteride dutasteride associated significantly increased risk depression hrtooltip hazard ratio citooltip confidence interval selfharm hr ci first months treatment associated increased risk suicide hr ci initial months therapy risk selfharm longer heightened whereas elevation risk depression lessened remained marginally increased hr ci absolute increase rate depression per patientyears selfharm per basis findings stated cases depression patients attributable encountered occasion cases selfharm attributable encountered differences rates depression selfharm suicide finasteride dutasteride suggesting specific used influence absolute risks selfharm depression remain low pharmacology inhibition complex involves binding nadph enzyme followed substrate specific substrates include testosterone progesterone androstenedione epitestosterone cortisol aldosterone deoxycorticosterone entire physiologic effect reduction unknown likely related excretion reduces steroid double bond testosterone active form dht thus inhibition results decreased amounts dht slight elevations testosterone estradiol levels reaction ratelimiting step testosterone reduction involves binding nadph enzyme followed beyond catalyst ratelimiting step testosterone reduction isoforms ii reduce progesterone deoxycorticosterone dihydrodeoxycorticosterone dhdoc vitro animal models suggest subsequent dht dhdoc lead neurosteroid metabolites effect cerebral function neurosteroids include allopregnanolone tetrahydrodeoxycorticosterone thdoc act potent positive allosteric modulators gabaa receptors antidepressant anxiolytic prosexual anticonvulsant present aqueous humor eye synthesized lens might help make aqueous humor potent antinatriuretic agent although different aldosterone formation kidney enhanced restriction dietary salt suggesting may help retain major hormone circulation normal cycling pregnant enzymes compensate degree absent conversion specifically local expression skin reductive dehydrogenase oxidative dehydrogenase dehydrogenase bph dht acts potent cellular androgen promotes prostate growth therefore inhibits alleviates symptoms bph alopecia male femalepattern baldness effect androgenic receptor activation reducing levels dht also reduces hair loss finasteride first introduced medical marketed treatment bph subsequently approved treatment pattern hair loss epristeride second introduced marketed treatment bph china dutasteride approved treatment bph subsequently approved pattern hair loss south korea japan patent protection finasteride dutasteride expired drugs available generic studied combination nonsteroidal antiandrogen bicalutamide treatment prostate